Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)

China flag China · Delayed Price · Currency is CNY
10.31
+0.08 (0.78%)
Feb 3, 2026, 3:00 PM CST
20.30%
Market Cap11.99B +21.9%
Revenue (ttm)9.84B +3.0%
Net Income546.80M
EPS0.47
Shares Out1.16B
PE Ratio21.72
Forward PE24.26
Dividend0.21 (2.05%)
Ex-Dividend Daten/a
Volume9,544,028
Average Volume18,572,163
Open10.29
Previous Close10.23
Day's Range10.24 - 10.41
52-Week Range8.13 - 13.06
Beta0.45
RSI43.95
Earnings DateApr 8, 2026

About SHA:600267

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was fo... [Read more]

Sector Healthcare
Founded 1956
Employees 7,994
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600267
Full Company Profile

Financial Performance

Financial Statements